Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086108A1 Hydrothermically processed compositions containing phytosterols
10/23/2003WO2003086102A2 Method for the production of potato juice products by means of food technology
10/23/2003WO2003086100A1 Dietary methods for canine performance enhancement
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003051315A3 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/23/2003WO2003014307A3 Antisense modulation of apolipoprotein(a) expression
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003WO2001000811A8 17867, a novel human aminopeptidase
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199580 Condensation of amine derivative with carboxylic acid derivatives to afford intermediate compound, followed by cyclization of intermediate compound in presence of acid; hyopoglycemic action
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199557 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/23/2003US20030199556 beta3- adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof
10/23/2003US20030199555 Indoline compounds and to pharmaceutical compositions containing them
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199528 Such as cis-8-(2-aminocyclohexylamino)-7-benzyl-3-methyl-1-(2-oxo-2-phenylehtyl)-3,7-dihydropurine-2,6-dione for inhibition of dipeptidyl peptidase-IV (DPP-IV); for treatment of diabetes/obesity
10/23/2003US20030199527 Such as 3-((4-methyl-benzyl)-(3,6-dimethyl-1-(2,4,6-trimethylphenyl)-1H-pyrazolo -(3,4-d)pyrimidin-4-yl)-amino)prop an-1-ol for treating/preventing Syndrome X; kits
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199515 Method for the preparation of crystalline tetrahydrobenzothiepines
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199492 Combination therapy
10/23/2003US20030199491 Quinoline derivatives having vegf inhibiting activity
10/23/2003US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199424 of a neuropathic condition, by administering anangiotensin II receptor I (AT1 receptor) antagonists
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199075 Compactin is provided and contacted with Actinomadura bacteria containing hydroxylase under hydroxylation condition to convert compactin to pravastatin, useful for lowering cholesterol levels in mammals
10/23/2003US20030199046 Processes and intermediates useful in preparing beta3-adrenergic receptor agonists
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003US20030198628 Harvesting pancrea tissue; grafting into body cavity; increase insulin concentration
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003CA2482716A1 Method of forming pancreatic .beta. cells from mesenchymal cells
10/23/2003CA2482703A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003CA2482669A1 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2482263A1 Therapeutic dry powder preparation
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481705A1 Hydrothermically processed compositions containing phytosterols
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481384A1 Aqueous dispersible steryl ester compositions
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480879A1 Tyrosine kinase inhibitors
10/23/2003CA2480858A1 Treatment of gastroparesis
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480814A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide
10/22/2003EP1354888A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354882A1 Dipeptidyl peptidase iv inhibitor
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354871A1 Biphenyl derivatives
10/22/2003EP1354870A1 Dihydroceramide desaturase inhibitors.
1 ... 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 ... 1298